XTANT MEDICAL HOLDINGS INC (XTNT) Earnings History & Surprises

NYSEARCA:XTNTUS98420P3082

Current stock price

0.61 USD
0 (0%)
Last:

XTNT Earnings overview

Past quarterly earnings results for XTANT MEDICAL HOLDINGS INC (XTNT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 11, 2026
Period
Q4 / 2025
EPS Estimate
-$0.01
Revenue Estimate
31.365M

Last Reported

Most Recent
Release Date
Mar 20, 2026
Period
Q3 / 2025
EPS Reported
$0.01
EPS Surprise
296.08%
Revenue Surprise
-0.30%

Beat Rate

Last 8 Quarters
50%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 0.01 -0.01 296.08% 125.00% 33.255M 33.354M -0.30% 19.04%
Q2 2025 0.02 -0.01 296.08% 166.67% 35.411M 31.977M 10.74% 18.26%
Q1 2025 0.00 -0.01 100.00% 100.00% 32.904M 31.824M 3.39% 18.05%
Q4 2024 -0.02 -0.02 -30.72% 33.33% 31.513M 32.436M -2.85% 12.11%
Q3 2024 -0.04 -0.03 -56.86% -157.14% 27.937M 29.886M -6.52% 11.66%
Q2 2024 -0.03 -0.02 -47.06% -50.00% 29.943M 29.274M 2.29% 48.00%
Q1 2024 -0.03 -0.02 -96.08% -50.00% 27.873M 26.265M 6.12% 55.34%
Q4 2023 -0.03 -0.03 -17.65% -50.00% 28.108M 27.081M 3.79% 84.07%
Q3 2023 0.07 -0.02 443.14% 333.33% 25.019M 19.278M 29.78% 73.00%
Q2 2023 -0.02 -0.02 1.96% - 20.232M 19.89M 1.72% 32.43%
Q1 2023 -0.02 -0.03 34.64% 33.33% 17.943M 15.504M 15.73% 38.46%
Q4 2022 -0.02 - 33.33% 15.27M - 9.31%
Q3 2022 -0.03 - -50.00% 14.462M - 4.97%
Q2 2022 -0.02 - - 15.277M - 2.02%
Q1 2022 -0.03 - - 12.959M - 3.32%
Q4 2021 -0.03 - -200.00% 13.97M - -0.32%
Q3 2021 -0.02 - 80.00% 13.777M - -1.71%
Q2 2021 - - 14.975M - 42.23%
Q1 2021 0.00 - 100.00% 12.542M - -15.13%
Q4 2020 -0.01 - - 14.015M - -
Q3 2020 -0.10 -0.11 10.87% - 14.016M 16.356M -14.31% -
Q2 2020 -0.19 -0.11 -69.34% - 10.529M 12.461M -15.50% -
Q1 2020 -0.19 - - 14.778M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

XTNT EPS Q2Q GrowthXTNT EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q4/21 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q3/26 Q4/27 0 100 -100 200 300

Revenue Historical Q2Q growth and Acceleration

XTNT Revenue Q2Q GrowthXTNT Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 20 40 60 80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
165.36%
Max EPS beat (4)
296.08%
Min EPS beat (4)
-30.72%

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
2.75%
Max Revenue beat (4)
10.74%
Min Revenue beat (4)
-2.85%

Analysis

In the last 4 quarters, XTNT has beaten EPS estimates in 3 out of 4 releases
XTNT has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, XTNT has beaten the EPS estimates by 165.4% on average.
In the last 4 quarters, XTNT has beaten the revenue estimates by 2.7% on average.

XTANT MEDICAL HOLDINGS INC / XTNT Earnings FAQ

Can you provide the last earnings date for XTANT MEDICAL HOLDINGS INC?

XTANT MEDICAL HOLDINGS INC (XTNT) last reported earnings on 3/20/2026.

Did XTNT stock beat earnings estimates in the most recent quarter?

XTANT MEDICAL HOLDINGS INC (XTNT) beat EPS estimates and missed revenue estimates in the most recent quarter.

How often does XTANT MEDICAL HOLDINGS INC (XTNT) beat earnings estimates?

In the last 4 quarters, XTANT MEDICAL HOLDINGS INC (XTNT) has beaten EPS estimates in 3 out of 4 releases.